Long‐term treatment outcomes in refractory rhinitis medicamentosa managed with nasal surgery
Authors:
- 23 July 2023
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 14 (3) , 630-638
Abstract
Background: Limited treatment options exist for refractory Rhinitis Medicamentosa (RM). The role of surgery after failed medical management is not well defined. Mucosal contact points and restricted airflow often perpetuate decongestant use. This study assessed the long‐term outcomes of nasal surgery in patients with refractory RM.Methods: A prospective cohort study of refractory RM treated with nasal surgery was performed with ≥12 months follow‐up. Refractory RM was defined as nasal decongestant use once per day continuously for ≥4 weeks despite medical therapy. Patients with concomitant sinus disease and nonrhinitis conditions were excluded. Sinonasal Outcome Test (SNOT22), Nasal Symptom Score (NSS), and nasal medication use were assessed. Patients who ceased decongestants were compared with ongoing users.Results: A total of 56 patients (age 48.4 [5.0] years, 50% female) were assessed. Median follow‐up was 3.4(1.6–6.2) years. Total cessation of decongestants was achieved in 91.1%, while 5.4% had intermittent use, and 3.6% reported daily use. Ongoing users had higher odds of concomitant asthma (40.0% vs. 3.9%; odds ratio [OR], 16.33 [1.7–159.75]; p = 0.036), reduced symptom improvement (ΔSNOT22, ‐4.6 [15.7] vs. 27.1 [17], p = 0.009 and ΔNSS, ‐1.0 [4.2] vs. ‐6.6 [5.1], p = 0.025), and greater ongoing use of nasal corticosteroid (60.0% vs. 5.9%; OR 24.0 [2.8–203.1]) and saline sprays (40% vs. 3.9%; OR 16.3 [1.7–159.8]) but showed no difference in allergy status (OR, 0.7[0.1–7.1]), previous surgery (OR, 1.0[0.1–10.2]), gastroesophageal reflux (OR 1.0[0.1–10.2], or underlying anxiety/depression (OR 6.1[0.8–45.9]) compared with those who ceased.Conclusion: Surgically re‐establishing a nasal airway was associated with long‐term decongestant cessation and symptom improvement in medically refractory RM.Keywords
This publication has 29 references indexed in Scilit:
- Psychometric validity of the 22‐item Sinonasal Outcome TestClinical Otolaryngology, 2009
- Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategiesClinical and Experimental Immunology, 2009
- Rhinitis Medicamentosa: Therapeutic Effect of Diode Laser Inferior Turbinate Reduction on Nasal Obstruction and Decongestant AbuseAmerican Journal of Rhinology, 2008
- Rhinitis medicamentosa and the stuffy noseJournal of Allergy and Clinical Immunology, 2006
- Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of useExpert Opinion on Drug Safety, 2006
- Rhinitis MedicamentosaTreatments in Respiratory Medicine, 2005
- An Evaluation of Nasal Response following Different Treatment Regimes of Oxymetazoline with Reference to Rebound CongestionAmerican Journal of Rhinology, 1997
- Extended Use of Topical Nasal DecongestantsThe Laryngoscope, 1997
- Decongestion Effect and Rebound Swelling of the Nasal Mucosa during 4-Week Use of OxymetazolineORL, 1994
- Rhinitis medicamentosaORL, 1983